Rigel pharmaceuticals currently has 1 hold rating and 2 buy ratings from wall street analysts. Get the latest rigel pharmaceuticals, inc.
(rigl) stock quote, history, news and other vital information to help you with your stock trading and investing.
Rigel pharmaceuticals stock cnn. The biotechnology company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.10) by $0.02. This former michigan state university basketball player started selling mortgages in his 20s now he's worth more than $11 billion. Find the latest rigel pharmaceuticals, inc.
Rigel pharmaceuticals stock was originally listed at a price of $63.99 in nov 29, 2000. This suggests a possible upside of 287.8% from the stock's current price. Rigel pharmaceuticals stock (rigl) to test drug for pneumonia.
Their forecasts range from $8.00 to $11.00. You can click the graphic below for the historical numbers, but it shows that as of june 2021 rigel pharmaceuticals had us$78.9m of debt, an increase on us$19.8m, over one year. But it also has us$153.4m in cash to offset that, meaning it has us$74.5m net cash.
The firm had revenue of $21.54 million for the quarter, compared to analysts' expectations of $24.16 million. On average, they expect rigel pharmaceuticals' stock price to reach $9.50 in the next year. According to the issued ratings of 2 analysts in the last year, the consensus rating for rigel pharmaceuticals stock is buy based on the current 2 buy ratings for rigl.
View the latest ratings for rigl. The drug passed mit harvard and fda compound test for ards. If you had invested in rigel pharmaceuticals stock at $63.99, your return over the last 21 years would have been.
The imperial college of london wil. Rigel pharmaceuticals last posted its earnings results on november 2nd, 2021. If you had bought rigel pharmaceuticals (nasdaq:rigl) stock a year ago, you could pocket a 49% gain today.
Rigel pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with hematologic disorders, cancer and rare immune diseases. The stock has a consensus analyst rating of buy. a buy rating indicates that analysts believe rigl will outperform the market and that investors should add to their positions of rigel pharmaceuticals. The median estimate represents a +152.37% increase from the last price of 3.17.
Nasdaqgs:rigl debt to equity history november 2nd 2021. Rigl | complete rigel pharmaceuticals inc. Drug developer gets small gain, analysts look to 1q for top deals.
With rigel pharmaceuticals stock trading at $2.60 per share, the total value of rigel pharmaceuticals stock (market capitalization) is $610.49m.
